American Century Companies Inc Biotechnology

American Century Companies Inc

$157 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CCCC C4 Therapeutics, Inc.	$109M	$227,000 0.0% of portfolio	141,986	Q1 2025 Added 6.89%
ENTA Enanta Pharmaceuticals Inc	$159M	$220,000 0.0% of portfolio	40,004	Q1 2025 Added 8.23%
TYRA Tyra Biosciences, Inc.	$432M	$217,000 0.0% of portfolio	23,431	Q1 2025 Added 5.82%
ERAS Erasca, Inc.	$205M	$216,000 0.0% of portfolio	158,081	Q1 2025 Reduced 56.52%
KOD Kodiak Sciences Inc.	$290M	$210,000 0.0% of portfolio	75,042	Q1 2025 Added 25.14%
RZLT Rezolute, Inc.	$209M	$196,000 0.0% of portfolio	67,925	Q1 2025 Added 5.16%
IDYA Ideaya Biosciences, Inc.	$1.06B	$195,000 0.0% of portfolio	11,908	Q1 2025 New
NKTX Nkarta, Inc.	$101M	$178,000 0.0% of portfolio	96,838	Q1 2025 Added 6.47%
DSGN Design Therapeutics, Inc.	$237M	$171,000 0.0% of portfolio	44,415	Q1 2025 Added 13.55%
TARA Protara Therapeutics, Inc.	$37.5M	$154,000 0.0% of portfolio	36,249	Q1 2025 New
PLRX Pliant Therapeutics, Inc.	$76.4M	$148,000 0.0% of portfolio	110,093	Q1 2025 Added 9.17%
FDMT 4 D Molecular Therapeutics, Inc.	$146M	$141,000 0.0% of portfolio	43,784	Q1 2025 Added 12.89%
CMPX Compass Therapeutics, Inc.	$311M	$139,000 0.0% of portfolio	73,682	Q1 2025 New
LRMR Larimar Therapeutics, Inc.	$149M	$138,000 0.0% of portfolio	64,284	Q1 2025 Added 14.19%
CDXC Chroma Dex Corp.	$420M	$135,000 0.0% of portfolio	19,676	Q1 2025 New
SEER Seer, Inc.	$126M	$128,000 0.0% of portfolio	76,001	Q1 2025 Reduced 0.41%
DAWN Day One Biopharmaceuticals, Inc.	$483M	$114,000 0.0% of portfolio	14,415	Q1 2025 New
THRD Third Harmonic Bio, Inc.	$219M	$109,000 0.0% of portfolio	31,667	Q1 2025 Added 16.21%
PRQR Pro Qr Therapeutics N.V.	$162M	$103,000 0.0% of portfolio	77,686	Q1 2025 Reduced 13.23%
TNGX Tango Therapeutics, Inc.	$588M	$89,000 0.0% of portfolio	65,146	Q1 2025 Reduced 41.02%
ALT Altimmune, Inc.	$206M	$85,000 0.0% of portfolio	17,175	Q1 2025 Reduced 61.61%
IOVA Iovance Biotherapeutics, Inc.	$494M	$83,000 0.0% of portfolio	24,974	Q1 2025 Reduced 80.28%
ZNTL Zentalis Pharmaceuticals, Inc.	$81.5M	$74,000 0.0% of portfolio	46,900	Q1 2025 Added 46.18%
EPIX Essa Pharma Inc.	$82.4M	$73,000 0.0% of portfolio	46,373	Q4 2024 Reduced 0.6%
ATAI Atai Life Sciences N.V.	$586M	$51,000 0.0% of portfolio	37,981	Q1 2025 New
MGNX Macrogenics Inc	$94.6M	$50,000 0.0% of portfolio	39,525	Q1 2025 Added 236.58%
LIFE A Tyr Pharma Inc	$53.2M	$42,000 0.0% of portfolio	22,703	Q1 2025 Reduced 74.23%
ORMP Oramed Pharmaceuticals Inc.	$82.7M	$41,000 0.0% of portfolio	19,591	Q1 2024 Added 1.56%
VIGL Vigil Neuroscience, Inc.	$228M	$36,000 0.0% of portfolio	20,258	Q1 2025 Added 1.44%
PYXS Pyxis Oncology, Inc.	$40M	$25,000 0.0% of portfolio	26,353	Q1 2025 Reduced 91.21%
HLVX Hille Vax, Inc.	$69.9M	$24,000 0.0% of portfolio	17,220	Q1 2025 Added 0.17%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	92,646	Q1 2025 Reduced 0.42%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.